NEWS

Friday, May 17 from 16:00 to 18:00: Seminar "Big Data in oncology: from basic applications to artificial intelligence" . Relatore il Prof. Moron Dalla Tor.

Per il collegamento cliccare qui

Educational Objectives

The Doctoral Program in Translational Medical and Surgical Sciences is intended to be a typical multidisciplinary doctoral program, in which the common denominator of the various research skills and activities is the specific phase of transition from the "bench," or laboratory bench, to the "bedside," i.e., clinical application in the real patient. This close link between laboratory and clinical research will enable rapid transfer to medical practice of discoveries and methodologies acquired through experimental studies. The close link with the clinic will also enable doctoral students to address real problems, ranging from diagnosis to therapy and from prevention to rehabilitation, however traceable to human pathology and patient care.

The rapid interchange between application contexts (clinical and laboratory) in its bi-directionality, will be able to bring back to the laboratory the results of clinical and epidemiological observation, while anchoring experimental research to issues that arise from insights and verifications carried out directly on humans.

Therefore, the PhD Program in Translational Medical and Surgical Sciences has as its ultimate goal the training of highly qualified PhDs, providing them with the opportunities, skills and technological resources to practice high-level translational research at public or private entities, domestic or foreign, including but not limited to Universities, Research Institutes and PharmaMed Industries.

Thematic Areas of Research

  1. Stem cells in the diagnosis and therapy of neoplasms, chronic and degenerative diseases, cardiovasculopathies, and diseases of the musculoskeletal system;
  2. Translational medicine and immunological dysregulation of respiratory diseases, digestive diseases, dermatological diseases, infectious diseases, oncological diseases,endocrinopathies, nephropathies, and vasculitides;
  3. Plasticity, function, and diagnostic-therapeutic use of genomic, transcriptomic, proteomic, and metabolomic platforms of cells, organs, and tissues in prevention or in the presence of neoplasms, infections, chronic, dysmetabolic, and degenerative diseases, obstetric-neonatal diseases, and in response to environmental factors, lifestyles, and drugs;
  4. Development and "theranostic" function of technologically advanced imaging and phenotyping platforms in prevention or in the presence of neoplasms, infections, chronic, dysmetabolic and degenerative diseases, obstetric-neonatal diseases and in response to environmental factors, lifestyles and drugs;
  5. Development and application of technologically advanced devices, including those of biological composition or origin, for the measurement and support or replacement of cell, tissue, and organ function in medical and surgical diseases;
  6. Advanced and innovative strategies for functional recovery and rehabilitation in prevention or in the presence of neoplasms, infections, chronic, dysmetabolic, and degenerative diseases, obstetrical-neonatal diseases, and in response to environmental factors, lifestyles, and drugs;
  7. Role of "governance" and organization of health care systems and services in the prevention and treatment of diseases of major social and economic importance, including diseases from environmental noxae and occupational diseases;
  8. Role of the microbiota and microbiome in translational medicine and surgery;
  9. Extraction and role of "big data" in translational medicine and surgery;
  10. Role of advanced technologies, including robotics, in translational surgery.

 

.

Modified on